Insider Transactions in Q1 2021 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 11
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$560,000
$112.83 P/Share
|
Jan 11
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jan 08
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.81%
|
$1,259,244
$114.72 P/Share
|
Jan 07
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,200,000
$120.0 P/Share
|
Jan 06
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,000
-0.02%
|
-
|
Jan 06
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$990,000
$110.96 P/Share
|
Jan 04
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-0.51%
|
$1,192,968
$108.55 P/Share
|
Jan 04
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.2%
|
$2,140,000
$107.15 P/Share
|
Jan 04
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.6%
|
$0
$0.99 P/Share
|
Jan 04
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-42.24%
|
$540,000
$108.7 P/Share
|
Jan 04
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Jan 04
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$535,000
$107.15 P/Share
|
Jan 04
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|